nOPV2

novel oral polio vaccine type 2 · Fidec Corporation

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for nOPV2, covering 2024-08-23 to 2025-07-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Mucosal Intestinal Immunity to Poliovirus Type-2 of nOPV2 at Birth Dose in Healthy IPV Vaccinated Infants [Phase 3]

See pricing